1. Home /
  2. Biotechnology


This Could Be the Next Biogen

Ginkgo Bioworks has great potential for science and investors.

This New ETF Is Totally a Wild

AdvisorShares Psychedelics ETF, which is adding Mindset Pharma and lists Cybin as a top holding, looks like a good trip.

Amarin Charts Are Charting a Course Toward Improvement

However, traders will need to show a lot of patience if they buy shares of the biopharmaceutical company.

Why Biopharmaceutical Dynavax Technologies Could Soar in 2022

Here's how traders can play the stock.

Have These 2 Biotech Names Bottomed?

Let's take a look at Axsome Therapeutics and TG Therapeutics.

If I Had to Bet, It Would Be on Biotech

If I'm going to speculate anywhere, it might be in the iShares Nasdaq Biotechnology ETF. Here's why.

Prospective Pickings Are Slim for This Annual Portfolio of Unloved Losers

The current candidates for the 2022 Tax-Loss Selling Recovery Portfolio are few and far between, with only a couple households names in the bunch.

3 Smaller Healthcare Stocks That Still Look Like Values in a Pricey Market

ProQR Therapeutics, Oscar Health and Hims & Hers Health appear to have promising futures.

A Day Never to Forget, Red-Hot Debt Market, Moderna Marches On, Biden Thumbs Up

Plus, Zscaler largely delivers for its owners with its latest results.

Moderna Poised to Get a Boost

The charts and indicators tell us the correction is over.